Christopher Donohue in New York, New York

Home New York New York

Christopher Donohue has Physician Assistant as his primary medical specialty. Their primary office is: 111 Broadway in New York, New York.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-9700 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2013 (around 11 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Christopher T Donohue Office Phone and Directions

Christopher Donohue
New York University
111 Broadway
New York, New York 10006
212-263-9700

Patient Ratings
Please rate your experience with Christopher Donohue below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-263-9700

Enter a starting address:

Healthcare Info for Christopher Donohue

Medical School: Sorry, his university is not listed
Graduation Year: 2013
The Primary Medical Specialty for Christopher Donohue is listed as: Physician Assistant
Approximate Years of Experience: 11
PAC (PECOS ID)#: 3577784412
NPI #: 1417384173
NPI Created On: 09/26/2013
NPI Last Updated Listed as: 06/28/2023
Primary Taxonomy Code: 363AS0400X
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Management and supervision of oxygen chamber therapy per session

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $36

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 787333365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Rhinology

Name of Drug #1: Acclarent Navwire